Three-month ESO Clinical Training Centre residencies/observerships at Hungary’s OECI-accredited comprehensive cancer centre. Fellows gain multidisciplinary exposure across stereotactic radiotherapy (CyberKnife/linac), robotic oncologic surgery (urology, gyn, abdominal), and systemic therapies (chemotherapy, targeted, immunotherapy, lymphoproliferative diseases), plus a 1-month rare tumours track. Training includes tumour boards, inpatient/outpatient care, and molecular pathology.
Eligibility Criteria:
-
Doctors specialized within the last 5 years (or completing by start).
-
From Europe, Mediterranean countries, or Latin America.
-
Prior ESO participation (≥1 ESO event or ≥5 e-ESO sessions).
-
Language: Good English required.
-
Track types available: Residency and Observership (programme-dependent).
Funding Details:
-
ESO economy travel reimbursement + EUR 2,000 gross per month.
-
Duration by track:
• CyberKnife & Stereotactic Radiotherapy — 3 months (Residency/Observership)
• Robotic Surgery — 3 months (Residency/Observership)
• Systemic Therapies (chemo/targeted/immuno & lymphoproliferative) — 3 months (Residency/Observership)
• Rare Tumours Therapy — 1 month (Residency/Observership)
-
ESCO credits per ESO policy: 120 (3 months) or 240 (6 months).
-
Trainee covers any medical-council registration; accommodation not provided.
Deadline: 17 September 2025.
Where to Go for Further Information:
-
Apply via ESO online portal.
-
General enquiries: [email protected].